THORNTON JOSEPH CLAY sold $22K of CLOV
THORNTON JOSEPH CLAY (Interim CFO) sold 4,630 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.67 on 2026-07-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the reported open-market sale amount, price, and post-transaction holdings by an officer (Interim CFO) under a pre-arranged 10b5-1 plan.
Market read
This is a routine insider sale disclosure; it is more relevant for sentiment monitoring than for a direct trading catalyst.
What to watch
The filing does not disclose any new company performance, guidance, or risk event; traders should avoid over-weighting it versus fundamentals and upcoming disclosures.
Background
The article is an SEC Form 4 insider transaction disclosure for Clover Health Investments, Corp. (DE).
Ticker impact
Clover Health insider Thornton Joseph Clay sold 4,630 shares at $4.67 under a 10b5-1 plan, per a newly filed Form 4.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal; this is company-specific insider trading with no disclosed operational or regulatory change.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerClover Health Investments, Corp. (DE)
Subject of the Form 4 insider transaction disclosure.
- insiderThornton Joseph Clay
Interim CFO who sold 4,630 shares at $4.67 under a 10b5-1 plan.
